comparemela.com

Kaia Gateway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kaia Health Raises Funds, Plans Expansion

Kaia Health Raises Funds, Plans Expansion Kaia Health announces it has raised $75 million in Series C funding (total raised to date: $125 million) to expand its clinical capabilities and transform the treatment path for musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care in the US and Europe. Fundraising was led by an unnamed leading growth equity fund with support from existing investors, including Optum Ventures, Eurazeo, capital300, Balderton Capital, Heartcore Capital, Symphony Ventures (investment vehicle of four times Major winner Rory McIlroy) and A Round Capital. The 2020 pandemic accelerated demand for a digital MSK solution, which saw Kaia Health grow its book of business by 600%. Globally, 60 million patients can access the Kaia Health digital MSK platform, according to the company, which notes that its virtual physical therapy technology provides real-time exercise feedback that has been third-party validated for its accuracy.

Big Money for Gene Editing, Engineering, Structure-Based Drug Design, and Data Management

April 29, 2021 April 29, 2021 | Illumina joins the Gates Foundation in a global pathogen genomics initiative, new money for immune profiling, and Benchling nets $200M for their cloud platform.   $375M: Fund for Growth-Stage Medtech, Digital Health  Endeavour Vision has closed Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the same strategy as its predecessor: to support growth-stage medtech and digital health innovations that advance the standard of care and bring efficiencies to healthcare systems. Both new and returning investors supported EMG II LP, including public pension funds, multi-manager funds, family offices, and high-net-worth individuals. EMG II LP builds on Endeavour Vision’s two decades of healthcare investing, which to date has included over USD 500 million invested in 42 companies 21 of which have exited via an acquisition or IPO. The fund has already supported seven companies with investm

Kaia Health grabs $75M on surging interest in its virtual therapies for chronic pain and COPD – TechCrunch

Kaia Health grabs $75M on surging interest in its virtual therapies for chronic pain and COPD New York headquartered Kaia Health, which offers AI-assisted digital therapies via a mobile app for chronic pain related to musculoskeletal (MSK) disorders and for Chronic Obstructive Pulmonary Disease (COPD), has raised a $75 million Series C. The round was led by an unnamed leading growth equity fund with support from existing investors, including Optum Ventures, Eurazeo, 3VC, Balderton Capital, Heartcore Capital, Symphony Ventures (golfer Rory McIlroy’s investment vehicle), and A Round Capital. The funding fast-follows a $26M Series B closed last summer. The pandemic has accelerated the uptake of telemedicine, generally and Kaia has, unsurprisingly, seen a particular surge of interest in its virtual treatments.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.